PMS2 and endometrial cancer: For instance, in the case of MLH1, the cumulative incidence of endometrial cancer by the age of 70 is 34%, whereas for mutations in the MSH2, MSH6, and PMS2 genes, it is 51%, 49%, and 24%, respectively.